Abstract:307 Objectives The assessment of reporter gene expression and receptor targeting using positron and optical molecular markers for tumor angiogenesis monitoring in vivo by a novel fully integrated imaging setup for simultaneous PET-optical data acquisition is investigated. Methods A transgenic prostate cancer cell line expressing the reporter gene luciferase downstream of the VEGF promoter was employed. 4×10E6 PC-3-hVEGF-Luc cells were injected subcutaneously in 15 nude male mice. Five weeks p.i. 18F-FDG (glucose metabolism) and/or 68Ga-RGD (angiogenesis) was injected at consecutive days for PET, each paired with luciferin injection after 15 min for dualmodal BLI-PET imaging. Immediately after luciferin injection, the mice were placed into a Biospace PhotonImager (photon counting mode) to monitor luciferase activity. Once saturation was reached the mice were displaced into the integrated PET-optical instrumentation setup. This setup consists of an unmodified Siemens Inveon small animal PET and a newly developed microlens based full ring optical imaging system (see abstract #) that was fully inserted into the PET9s gantry. Both modalities were operated in static data acquisition modes. Results Photon counting revealed typical tumor luciferin uptake kinetics reaching a maximum steady state after 20 min ±3 min p.i. Optical signal intensities of corresponding quantity as compared to the PhotonImager signal have been acquired with the integrated optical imaging system. Information gained with PET were either complementary (18F-FDG) or consistent (68Ga-RGD). PET data were reconstructed using OSEM. Optical projection data were back-projected onto the mice surface segmented from either the PET emission or transmission data by inverse ray tracing. Conclusions Preclinical application of fully simultaneous BLI-PET has been demonstrated. Both modalities were operated entirely independently even though data were acquired simultaneously

Optimized in vivo multispectral bioluminescent imaging of tumor biology using engineered BRET reporters

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Highly bright and stable NIR-BRET with blue-shifted coelenterazine derivatives for deep-tissue imaging of molecular events in vivo

Brightening up Biology: Advances in Luciferase Systems for in Vivo Imaging

Fluorophore-NanoLuc BRET Reporters Enable Sensitive in Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.

NIR-II bioluminescence for in vivo high contrast imaging and in situ ATP-mediated metastases tracing

Harnessing Bioluminescence: A Comprehensive Review of In Vivo Imaging for Disease Monitoring and Therapeutic Intervention

Quantitative in vivo dual-color bioluminescence imaging in the mouse brain

A dual-luciferase bioluminescence system for the assessment of cellular therapies

Creating coveted bioluminescence colors for simultaneous myriad-color bioimaging

A novel luciferase fusion protein for highly sensitive optical imaging: from single-cell analysis to in vivo whole-body bioluminescence imaging

Engineered Amber-Emitting Nano Luciferase and Its Use for Immunobioluminescence Imaging In Vivo

ATP-Independent Bioluminescent Reporter Variants To Improve in Vivo Imaging

Amino‐Acid‐Encoded Supramolecular Nanostructures for Persistent Bioluminescence Imaging of Tumor

Bimodal positron-optical imaging of reporter gene expression and receptor targeting in mice

Luciferase-Loaded Calcium Phosphate Nanoparticles for Persistent Bioluminescence Imaging of Orthotopic Breast Tumors

An optimized bioluminescent substrate for non-invasive imaging in the brain

Image-guided Simulation for Bioluminescence Tomographic Imaging.

Recent Advances in Bioluminescence Tomography: Methodology and System As Well As Application

324. Development of Bioluminescence Tomography for Three-Dimensional Real Time Imaging of Gene Expression

Imaging of Red-Shifted Light From Bioluminescent Tumors Using Fluorescence by Unbound Excitation From Luminescence